Emphysema COPD Treatment

Stem Cell Treatment for Emphysema and COPD Offered at the Lung Institute

The Lung Institute is pleased to offer treatment for emphysema and COPD using stem cell therapy. Chronic obstructive pulmonary disease (COPD) is a category of lung diseases that includes both emphysema and chronic bronchitis. If you’re living with COPD, you may experience persistent coughing and difficulty breathing, among other symptoms.

Although there is currently no cure for emphysema or COPD, treatment may help improve your quality of life. At the Lung Institute, we offer stem cell therapy, which has the potential to promote healing from within the lungs. Our stem cell therapy procedure is completed in three steps, which are performed on an outpatient basis. First, we collect a sample of your cells using one of the following two methods:

  • Bone marrow extraction — We can collect your sample from your bone marrow. When compared to peripheral blood, bone marrow tends to contain a greater number of adult stem cells.
  • Blood draw — We can also extract your sample directly from your bloodstream. This method is less invasive than the one used during bone marrow extraction.

After collecting your sample, we take it to our onsite lab, where we separate the stem cells contained therein from the rest of the sample. Finally, we return the concentrated stem cells to your bloodstream. Regardless of whether we collect your sample from your blood or your bone marrow, you won’t have to worry about your system rejecting the concentrated stem cells, as the cells will be coming directly from your own body.

If you would like more information on how to use stem cell therapy for the treatment of emphysema or COPD, please call the Lung Institute today at (800) 729-3065. As the only clinic worldwide that is exclusively focused on treating lung disease, we look forward to helping you breathe easier.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.